The Competition Commission of Singapore (CCS) has initiated the second phase of a review on the proposed multibillion-dollar merger between French lens maker Essilor International and Italian eyewear manufacturer Luxottica Group.
On September 13, CCS received a notification for decision on whether the proposed merger would infringe the Competition Act. The phase 1 review was completed on November 13, but the CCS was unable to conclude that the proposed transaction would not raise competition concerns.
In particular, it found that the two companies are the biggest players in their respective markets, which means that a merger could give them substantial market power in the complementary segments of ophthalmic lenses, prescription frames and sunglasses.
Full Content: Global Competition Review
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
EU Extends Support for Farms and Fisheries Amid Market Disruptions
May 5, 2024 by
CPI
Sony and Apollo Bid $26 Billion for Paramount Acquisition
May 5, 2024 by
CPI
Goldman Sachs Resolves Decade-Old Metal-Rigging Class Action Lawsuit
May 5, 2024 by
CPI
Italian Antitrust Ruling Puts Halt on Intesa Sanpaolo’s Fintech Ambitions
May 5, 2024 by
CPI
Google Antitrust Case: Closing Arguments Conclude
May 5, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI